 |
| Seth Berkley President and Chief Executive Officer, International AIDS Vaccine Initiative, James Geraghty, Senior Vice President, Genzyme, and Melinda Moree, Interim Chief Executive Officer, BIO Ventures for Global Health |
Despite significant basic knowledge about global diseases, drug research and development has been hindered by market forces and a lack of a profitable patient base. Out of necessity, innovators in the global health arena have created complex networks and cross-sector collaborations to advance the development of drugs, vaccines, and diagnostics for neglected diseases. Hear them discuss the formation of these entities and what lessons might be learned for similarly neglected diseases of the developed world.
Moderator:
Melinda Moree, Interim Chief Executive Officer, BIO Ventures for Global Health
Speakers:
Seth Berkley, President and Chief Executive Officer, International AIDS Vaccine Initiative
James Geraghty, Senior Vice President, Genzyme
Hannah E. Kettler, Ph.D., Economist and Senior Program Officer, Global Health Advocacy, Bill & Melinda Gates Foundation.
Mike Powell, General Partner, Sofinnova Ventures
Ken Stuart, President and Director, Seattle Biomedical Research Institute
Back to Program Schedule and Sessions |
